NCT06379022

Proteomic Analysis of Newly Restored Single Implants

Name: Clinical Trial NCT06379022
Creator: Aristotle University Of Thessaloniki
Keywords: Peri-Implantitis,Peri-implant Mucositis,Periodontal Diseases, Plaque control, behavioral, clinical trial, Greece

Clinical and Cellular Responses of Tissues at Newly Restored Single Implants Compared to Contralateral Natural Teeth During Their First Year of Functional Loading

Aristotle University Of Thessaloniki·ClinicalTrials.gov·behavioralCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Peri-Implantitis,Peri-implant Mucositis,Periodontal Diseases
Drug/Device/Intervention: Plaque control
Study type: Observational
Intervention type: behavioral

Sponsor & location

Primary sponsor: Aristotle University Of Thessaloniki
Location: Thessaloniki, Greece

Timeline & enrollment

Phase: N/A
Start date: Dec 03, 2018
End date: Nov 29, 2019
Enrollment: 10 participants

Primary outcome

Probing pocket depth,Protein expression

Summary

In 10 systemically healthy non-smokers, free of periodontitis, one newly restored implant (baseline-T0) and one corresponding tooth were followed over 12 months (T1). All implants were screw-retained, and platform-switched. Oral hygiene was closely monitored during the study. Probing pocket depth (PPD), attachment levels (CAL), bleeding and plaque indices and crevicular fluid were collected from an implant-site (PICF) and a tooth-site (GCF). Total proteomic profiles in PICF and GCF were investigated using label-free quantitative proteomics.

ICD-10 classifications

Other periodontal diseasesGingivitis and periodontal diseasesPeriodontal disease, unspecifiedChronic periodontitisPeriodontosis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06379022
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06379022 through Pure Global AI's free database. This phase not specified trial is sponsored by Aristotle University Of Thessaloniki and is currently Completed. The study focuses on Peri-Implantitis,Peri-implant Mucositis,Periodontal Diseases. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.